|
Symposium
[Free Online] Oncology Business Development and Partnering: perspectives and advice from buyers
Speakers:
Lizabeth Leveille, Merck; Lesley Stolz, JNJ
Organizers:
Sarah Bodary, PhD; Jeff McMahon, PhD; Jimmy Zhang, PhD
Date:
2024-03-15
Time:
8:30-11:30 Pacific Time
Registration fee:
0
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-03-14
(it will close sooner if the seating cap is reached)
About the Topic
The symposium is intended to bring together BD leaders from pharma and venture with private biotechs focusing on oncology. The forum will provide "buyers" the opportunity to share their wish lists and advice on what is of interest from a Search and Evaluation perspective through brief presentations. Biotech participants will have an opportunity to pose questions to specific panel members after the presentations and in a panel discussion.
| Time (PT) |
Time (ET) |
Speaker |
| 8:30-8:40 AM |
11:30-11:40 AM |
Shichang Miao, PhD, PBSS |
| 8:40-8:45 AM |
11:40-11:45 AM |
Sarah Bodary, PhD, Darwin Bodary Consulting |
| 8:45-9:10 AM |
11:45 AM-12:10 PM |
Lizabeth Leveille, PhD, Vice President, Merck & Co |
| 9:10-9:35 AM |
12:10-12:35 PM |
Lesley Stolz, PhD, Vice President, Johnson & Johnson |
| 9:35-10:15 AM |
12:35-1:15 PM |
Panel Discussion and Wrap-up |
2024-08-14, [Free Online] Advances in Cancer Therapeutics (Organized by PBSS and BioScience Forum)
|
2024-08-22, [Free Online] Diabetes and Obesity Treatments: Current and Emerging Landscapes of GLP-1, GIP, and Beyond
|
2024-09-10, [In-Person] Translational PK/PD and Human Dose Projection for Antibodies/ADCs and Novel Therapeutic Modalities
|
2024-09-20, [In-Person] Nonclinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings
|
2024-09-25, [Free Online] Development of Protein Degraders: Computational Modeling, Medicinal Chemistry and Early Development
|
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
|
2024-10-25, [Free Online Workshop] Unleashing the Power of Real-World Evidence / Data (RWE/RWD) to Facilitate Drug Discovery, Development, and Beyond
|
2024-11-01, [In-Person] Clinical Pharmacology Studies on Hepatic and Renal Impairments for NDA Filing: Strategies, Design, Conduct, Analysis and Regulatory Aspects
|
2024-11-13, [Free Online Workshop] Career Transition for Research Scientists: Business Development & BioPartnering
|
2024-11-15, [In-Person] Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapeutics
|
2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
|
|
Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Simulations Plus
GastroPlus X: Science, models & refined algorithms—now with intuitive interface, faster processing & streamlined workflows for faster PBPK modeling.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Submit a Text Ad
|